Home � News From ETHIOPIA � News From Healthcare and Medical
Ethiopia : Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia in ETHIOPIA
| TI Ref No: | 503245490 |
| Date : | 24 Apr 2024 |
| Description: | Ethiopia : Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia, ETHIOPIA |
| Document Type | Procurement News |
|
Click Here For Login If you are registered member, kindly login to view full details of this tender notice. |
|
|
Subscribe Now If you are not a subscriber, kindly contact nikhil.j@tendersinfo.com OR Naorm@export.gov.il |